Cas:38901-29-0 4-[2-(Trifluoromethyl)phenyl]-3-thiosemicarbazide manufacturer & supplier

We serve Chemical Name:4-[2-(Trifluoromethyl)phenyl]-3-thiosemicarbazide CAS:38901-29-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-[2-(Trifluoromethyl)phenyl]-3-thiosemicarbazide

Chemical Name:4-[2-(Trifluoromethyl)phenyl]-3-thiosemicarbazide
CAS.NO:38901-29-0
Synonyms:1-amino-3-[2-(trifluoromethyl)phenyl]thiourea
Molecular Formula:C8H8F3N3S
Molecular Weight:235.22900
HS Code:2930909090

Physical and Chemical Properties:
Melting point:159-161ºC
Boiling point:290.9ºC at 760mmHg
Density:1.471g/cm3
Index of Refraction:1.607
PSA:82.17000
Exact Mass:235.03900
LogP:3.02970

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-amino-3-[2-(trifluoromethyl)phenyl]thiourea chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-amino-3-[2-(trifluoromethyl)phenyl]thiourea physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-amino-3-[2-(trifluoromethyl)phenyl]thiourea Use and application,1-amino-3-[2-(trifluoromethyl)phenyl]thiourea technical grade,usp/ep/jp grade.


Related News: U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year. 4-[2-(Trifluoromethyl)phenyl]-3-thiosemicarbazide manufacturer U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year. 4-[2-(Trifluoromethyl)phenyl]-3-thiosemicarbazide supplier Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 4-[2-(Trifluoromethyl)phenyl]-3-thiosemicarbazide vendor Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 4-[2-(Trifluoromethyl)phenyl]-3-thiosemicarbazide factory U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year.